Premium Bilastine API in Pakistan: Reliable Raw Material Supply for Pharmaceutical Formulators

Product Name: Bilastine (Active Pharmaceutical Ingredient)

Supplier / Distributor: Morgan

Therapeutic Category: Second-Generation H1-Antihistamine

Indications: Allergic Rhinoconjunctivitis, Urticaria

Compliance Notice: This technical data page is strictly for B2B pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and analytical laboratories. The Bilastine distributed by Morgan is a highly purified Active Pharmaceutical Ingredient (API) intended exclusively for commercial formulation and laboratory R&D. It is not a finished drug product.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview and Mechanism of Action

Bilastine is a highly selective, non-sedating small-molecule Active Pharmaceutical Ingredient (API). Within allergy and immunology pharmacology, it is classified as a second-generation H1-antihistamine. For pharmaceutical formulation scientists, this active ingredient provides a robust foundation for developing modern, well-tolerated therapeutics aimed at managing chronic and acute allergic conditions.

The pharmacological profile of Bilastine is characterized by its precise mechanism of action. It functions as a highly specific, reversible antagonist at the peripheral histamine H1-receptor. During an allergic response, the degranulation of mast cells releases histamine, which binds to H1 receptors to trigger vasodilation, increased vascular permeability, erythema, and intense pruritus (itching).

By competitively binding to these receptors, Bilastine actively prevents histamine-induced inflammatory cascades. A critical clinical advantage of this API is its molecular structure, which prevents it from crossing the blood-brain barrier to any significant degree. Consequently, it exhibits negligible affinity for central nervous system (CNS) muscarinic, serotonergic, or dopaminergic receptors. This translates to an anti-allergic therapeutic with virtually no sedative effects or anticholinergic adverse events.

In commercial pharmaceutical manufacturing, this active ingredient is most frequently formulated into 20 mg immediate-release oral solid tablets or oral solutions for pediatric applications.

Sourcing Bilastine in Pakistan: Morgan’s Supply Network

Developing and commercializing advanced antihistamine formulations requires a highly resilient and traceable raw material pipeline. Procuring specialty non-sedating APIs for local commercial manufacturing frequently involves navigating extended lead times, rigid customs bottlenecks, and highly complex regulatory compliance documentation. Sourcing Bilastine Pakistan through Morgan’s localized distribution network directly mitigates these complex supply chain risks.

Morgan sources commercial-scale and pilot-scale quantities from global manufacturing partners operating in strict adherence to ICH Q7 Good Manufacturing Practice (GMP) guidelines. Partnering with Morgan as your primary supply vendor secures several operational provisions for your manufacturing facility:

• DRAP Submission Assistance: Morgan coordinates with DRAP-registered API manufacturers to obtain and forward the necessary compliance documentation on your behalf. This includes the open part of the Drug Master File (DMF), comprehensive impurity profiles, and accelerated stability data to strictly support your Drug Regulatory Authority of Pakistan (DRAP) dossier submissions.
• Supply Chain Stability: Our localized API inventory management eliminates international transit variables. Whether you require a standard pilot batch or are scaling up a high-volume Bilastine api Pakistan procurement order, we help ensure that your commercial batch schedules and production timelines are met without costly line stoppages or raw material shortages.
• Batch-to-Batch Uniformity: Every shipment coordinated by Morgan includes a detailed Certificate of Analysis (CoA) issued by the original manufacturer. We ensure our supplied batches maintain consistent chemical purity, controlled moisture limits, and a precise particle size distribution (PSD) for predictable behavior during dry blending, granulation, and tablet compression processes.

Technical Specifications for QA & R&D

The Bilastine API supplied by Morgan undergoes exacting analytical testing at the source to meet current international pharmacopeial standards.

• Chemical Name: 2-[4-(2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl)phenyl]-2-methylpropanoic acid
• CAS Number: 202189-78-4
• Appearance: White to off-white crystalline solid powder
• Molecular Formula: C28H37N3O3
• Molecular Weight: 463.61 g/mol
• Assay / Purity (HPLC): ≥ 99.0%
• Solubility Profile: Bilastine is practically insoluble in water but soluble in specific organic solvents and pH-adjusted aqueous buffers. Detailed solubility parameters and pKa values are documented in the technical data sheet to assist your analytical R&D teams with dissolution profiling and pre-formulation stability studies.

Manufacturing and Handling Guidelines for Formulators

While Bilastine is a widely prescribed antihistamine with an excellent safety profile, the pure active ingredient is a concentrated pharmacological compound. Facilities processing this API must enforce standard occupational exposure limits (OEL) to protect personnel on the manufacturing floor.

• Storage Conditions: Store the raw API powder in securely closed, light-resistant containers. Maintain climate-controlled conditions as specified by the batch protocol (typically controlled room temperature, strictly protected from excessive heat and ambient humidity) to prevent degradation and maintain structural integrity.
• Occupational Safety: Personnel handling the pure API powder must follow standard industrial containment protocols. Processing requires appropriate Personal Protective Equipment (PPE), including P3/N95 industrial dust masks or respirators, chemical-resistant nitrile gloves, and full protective facility garments. Dispensing, milling, and compounding stages must be executed within localized exhaust ventilation systems or dedicated weighing booths to prevent the inhalation of airborne particulates and facility cross-contamination.

Distributor Disclaimer: Morgan Chemicals is a pharmaceutical raw material trading and distribution company. This API is sourced from DRAP-registered, GMP-certified manufacturing partners. Morgan Chemicals does not manufacture APIs, does not hold DRAP manufacturing registration, and does not sell finished medicines. This product is supplied exclusively to licensed pharmaceutical companies, CMOs, and research facilities in Pakistan — not for individual or consumer sale.